Zuri A. Murrell, MD, on Rising Colorectal Cancer Rates in Younger People
The cancer specialist from Cedars-Sinai spoke about the observed increase of colorectal cancer in younger individuals, as well as the significantly higher incidence and death rates in black people.
According to the American Cancer Society, colorectal cancer is the second-leading cause of cancer deaths in the US in men and women combined.
Further, while this disease typically affects older individuals, colorectal cancer is increasingly affecting people under the age of 50, who are now anticipated to account for 12% of all US cases in 2020. According to Zuri A. Murrell, MD, a colorectal surgeon and cancer specialist at Cedars-Sinai, obesity, diabetes, smoking, and a family history of colorectal cancer may all play a role in this observed increase
In an interview with CancerNetwork®, Murrell discussed this observed increase in younger individuals, as well as the significantly higher incidence and death rates in black people.
This segment comes from the CancerNetwork® portion of the MJH Life Sciences Medical World News, airing daily on all MJH Life Sciences channels.
Reference:
American Cancer Society. Key Statistics for Colorectal Cancer. American Cancer Society website. Last revised August 31, 2020. Accessed September 14, 2020. https://www.cancer.org/cancer/colon-rectal-cancer/about/key-statistics.html
FDA Approves Encorafenib/Cetuximab Plus mFOLFOX6 for Advanced BRAF V600E+ CRC
December 20th 2024The FDA has granted accelerated approval to encorafenib in combination with cetuximab and mFOLFOX6 for patients with metastatic colorectal cancer with a BRAF V600E mutation, as detected by an FDA-approved test.
